Global Infectious Disease Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Infectious Disease Diagnostics market size was valued at US$ 26692 million in 2025 and is forecast to a readjusted size of US$ 36133 million by 2032 with a CAGR of 4.5% during review period.
Infectious Disease Diagnostics refers to a system of in-vitro diagnostic reagents, instruments, automated platforms, informatics systems, and quality-control solutions used to detect, identify, type, quantify, and clinically interpret pathogens or infection-related markers in human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. It targets infectious diseases caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens, and may detect nucleic acids, antigens, antibodies, toxins, resistance genes, or host immune-response markers. The field covers molecular diagnostics, immunodiagnostics, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, point-of-care testing, multiplex panels, and sequencing. It is widely used in clinical diagnosis, infection control, antimicrobial stewardship, public health surveillance, border quarantine, and epidemic early warning, supporting early detection, diagnosis, isolation, treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostics is evolving from single-outbreak emergency demand into a long-term sector jointly driven by clinical care, public health security, and healthcare-system resilience. Emerging infectious diseases, seasonal respiratory outbreaks, chronic viral infection management, tuberculosis and antimicrobial resistance control, hospital-acquired infection monitoring, and rational antimicrobial use are all driving continuous investment in rapid, precise, and traceable testing capabilities across healthcare institutions and public health systems. Government documents continue to strengthen disease control systems, medical-public health coordination, and interconnection of pathogen testing data, while corporate annual reports show that global diagnostic leaders regard infectious disease testing as an important strategic direction across molecular diagnostics, immunodiagnostics, and microbiology. Multi-platform integration, multiplex pathogen testing, automated workflows, and data-driven surveillance will continue to expand the value boundary of the industry.The infectious disease diagnostics industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, healthcare cost control, and product homogenization. After the pandemic, demand for certain single-pathogen tests has normalized, requiring companies to shift from short-cycle outbreak-driven products toward multi-scenario portfolios covering respiratory, blood-borne, gastrointestinal, reproductive tract, hospital-acquired infection, and antimicrobial resistance monitoring. Molecular diagnostics require high sensitivity, specificity, contamination control, and laboratory workflow capability. Immunodiagnostics emphasize antigen and antibody quality as well as lot-to-lot consistency, while microbiological diagnostics depend on sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. Future competition will not be limited to product pricing, but will depend on clinical evidence, test menus, platform compatibility, channel services, quality systems, and supply-chain resilience.Downstream demand is shifting from ?whether testing is available? to ?rapid differentiation, precise typing, medication guidance, and data reporting.? Large hospitals increasingly emphasize coordination among emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams, using rapid etiological testing and resistance monitoring to shorten diagnostic time, optimize anti-infective therapy, and reduce nosocomial transmission risk. Primary healthcare institutions need tests that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems emphasize pathogen-spectrum monitoring, regional epidemic trend assessment, and early warning. As medical-public health collaboration and infectious disease surveillance systems improve, infectious disease diagnostics will become a key infrastructure linking clinical treatment efficiency, hospital operational quality, and public health governance.
This report is a detailed and comprehensive analysis for global Infectious Disease Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infectious Disease Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin, and global market share of Infectious Disease Diagnostics from 2021 to 2026.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infectious Disease Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Diagnostics.
Chapter 13, to describe Infectious Disease Diagnostics research findings and conclusion.
Infectious Disease Diagnostics refers to a system of in-vitro diagnostic reagents, instruments, automated platforms, informatics systems, and quality-control solutions used to detect, identify, type, quantify, and clinically interpret pathogens or infection-related markers in human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. It targets infectious diseases caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens, and may detect nucleic acids, antigens, antibodies, toxins, resistance genes, or host immune-response markers. The field covers molecular diagnostics, immunodiagnostics, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, point-of-care testing, multiplex panels, and sequencing. It is widely used in clinical diagnosis, infection control, antimicrobial stewardship, public health surveillance, border quarantine, and epidemic early warning, supporting early detection, diagnosis, isolation, treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostics is evolving from single-outbreak emergency demand into a long-term sector jointly driven by clinical care, public health security, and healthcare-system resilience. Emerging infectious diseases, seasonal respiratory outbreaks, chronic viral infection management, tuberculosis and antimicrobial resistance control, hospital-acquired infection monitoring, and rational antimicrobial use are all driving continuous investment in rapid, precise, and traceable testing capabilities across healthcare institutions and public health systems. Government documents continue to strengthen disease control systems, medical-public health coordination, and interconnection of pathogen testing data, while corporate annual reports show that global diagnostic leaders regard infectious disease testing as an important strategic direction across molecular diagnostics, immunodiagnostics, and microbiology. Multi-platform integration, multiplex pathogen testing, automated workflows, and data-driven surveillance will continue to expand the value boundary of the industry.The infectious disease diagnostics industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, healthcare cost control, and product homogenization. After the pandemic, demand for certain single-pathogen tests has normalized, requiring companies to shift from short-cycle outbreak-driven products toward multi-scenario portfolios covering respiratory, blood-borne, gastrointestinal, reproductive tract, hospital-acquired infection, and antimicrobial resistance monitoring. Molecular diagnostics require high sensitivity, specificity, contamination control, and laboratory workflow capability. Immunodiagnostics emphasize antigen and antibody quality as well as lot-to-lot consistency, while microbiological diagnostics depend on sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. Future competition will not be limited to product pricing, but will depend on clinical evidence, test menus, platform compatibility, channel services, quality systems, and supply-chain resilience.Downstream demand is shifting from ?whether testing is available? to ?rapid differentiation, precise typing, medication guidance, and data reporting.? Large hospitals increasingly emphasize coordination among emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams, using rapid etiological testing and resistance monitoring to shorten diagnostic time, optimize anti-infective therapy, and reduce nosocomial transmission risk. Primary healthcare institutions need tests that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems emphasize pathogen-spectrum monitoring, regional epidemic trend assessment, and early warning. As medical-public health collaboration and infectious disease surveillance systems improve, infectious disease diagnostics will become a key infrastructure linking clinical treatment efficiency, hospital operational quality, and public health governance.
This report is a detailed and comprehensive analysis for global Infectious Disease Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infectious Disease Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Infectious Disease Diagnostics
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infectious Disease Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Blood Sample
- Respiratory Sample
- Urine Sample
- Other
- Molecular Diagnostics
- Immunodiagnostics
- Culture & AST
- POCT Rapid Tests
- Other
- Respiratory Infections
- Hepatitis & Blood-borne
- Sexually Transmitted Infections
- Gastrointestinal Infections
- Other
- Public Hospitals
- Third-party Independent Laboratory
- Other
- BD
- Danaher
- Abbott
- bioM?rieux
- Hologic
- Thermo Fisher Scientific
- Roche
- DiaSorin
- QuidelOrtho
- Siemens Healthineers
- Qiagen
- Bio-Rad
- Wondfo Biotech
- Autobio
- Daan Gene
- Innovita
- Hybribio
- BioPerfectus
- Sansure
- Liferiver
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Diagnostics, with revenue, gross margin, and global market share of Infectious Disease Diagnostics from 2021 to 2026.
Chapter 3, the Infectious Disease Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infectious Disease Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Diagnostics.
Chapter 13, to describe Infectious Disease Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Disease Diagnostics by Type
1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 Blood Sample
1.3.4 Respiratory Sample
1.3.5 Urine Sample
1.3.6 Other
1.4 Classification of Infectious Disease Diagnostics by Technology
1.4.1 Overview: Global Infectious Disease Diagnostics Market Size by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Technology in 2025
1.4.3 Molecular Diagnostics
1.4.4 Immunodiagnostics
1.4.5 Culture & AST
1.4.6 POCT Rapid Tests
1.4.7 Other
1.5 Classification of Infectious Disease Diagnostics by Test Item
1.5.1 Overview: Global Infectious Disease Diagnostics Market Size by Test Item: 2021 Versus 2025 Versus 2032
1.5.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Test Item in 2025
1.5.3 Respiratory Infections
1.5.4 Hepatitis & Blood-borne
1.5.5 Sexually Transmitted Infections
1.5.6 Gastrointestinal Infections
1.5.7 Other
1.6 Global Infectious Disease Diagnostics Market by Application
1.6.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Third-party Independent Laboratory
1.6.4 Other
1.7 Global Infectious Disease Diagnostics Market Size & Forecast
1.8 Global Infectious Disease Diagnostics Market Size and Forecast by Region
1.8.1 Global Infectious Disease Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Infectious Disease Diagnostics Market Size by Region, (2021-2032)
1.8.3 North America Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.6 South America Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Infectious Disease Diagnostics Product and Solutions
2.1.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BD Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Infectious Disease Diagnostics Product and Solutions
2.2.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Infectious Disease Diagnostics Product and Solutions
2.3.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Abbott Recent Developments and Future Plans
2.4 bioM?rieux
2.4.1 bioM?rieux Details
2.4.2 bioM?rieux Major Business
2.4.3 bioM?rieux Infectious Disease Diagnostics Product and Solutions
2.4.4 bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 bioM?rieux Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Infectious Disease Diagnostics Product and Solutions
2.5.4 Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Hologic Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Infectious Disease Diagnostics Product and Solutions
2.6.4 Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Infectious Disease Diagnostics Product and Solutions
2.7.4 Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Roche Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Infectious Disease Diagnostics Product and Solutions
2.8.4 DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 QuidelOrtho
2.9.1 QuidelOrtho Details
2.9.2 QuidelOrtho Major Business
2.9.3 QuidelOrtho Infectious Disease Diagnostics Product and Solutions
2.9.4 QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 QuidelOrtho Recent Developments and Future Plans
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business
2.10.3 Siemens Healthineers Infectious Disease Diagnostics Product and Solutions
2.10.4 Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Siemens Healthineers Recent Developments and Future Plans
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business
2.11.3 Qiagen Infectious Disease Diagnostics Product and Solutions
2.11.4 Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Qiagen Recent Developments and Future Plans
2.12 Bio-Rad
2.12.1 Bio-Rad Details
2.12.2 Bio-Rad Major Business
2.12.3 Bio-Rad Infectious Disease Diagnostics Product and Solutions
2.12.4 Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Bio-Rad Recent Developments and Future Plans
2.13 Wondfo Biotech
2.13.1 Wondfo Biotech Details
2.13.2 Wondfo Biotech Major Business
2.13.3 Wondfo Biotech Infectious Disease Diagnostics Product and Solutions
2.13.4 Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Wondfo Biotech Recent Developments and Future Plans
2.14 Autobio
2.14.1 Autobio Details
2.14.2 Autobio Major Business
2.14.3 Autobio Infectious Disease Diagnostics Product and Solutions
2.14.4 Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Autobio Recent Developments and Future Plans
2.15 Daan Gene
2.15.1 Daan Gene Details
2.15.2 Daan Gene Major Business
2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Daan Gene Recent Developments and Future Plans
2.16 Innovita
2.16.1 Innovita Details
2.16.2 Innovita Major Business
2.16.3 Innovita Infectious Disease Diagnostics Product and Solutions
2.16.4 Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Innovita Recent Developments and Future Plans
2.17 Hybribio
2.17.1 Hybribio Details
2.17.2 Hybribio Major Business
2.17.3 Hybribio Infectious Disease Diagnostics Product and Solutions
2.17.4 Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Hybribio Recent Developments and Future Plans
2.18 BioPerfectus
2.18.1 BioPerfectus Details
2.18.2 BioPerfectus Major Business
2.18.3 BioPerfectus Infectious Disease Diagnostics Product and Solutions
2.18.4 BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 BioPerfectus Recent Developments and Future Plans
2.19 Sansure
2.19.1 Sansure Details
2.19.2 Sansure Major Business
2.19.3 Sansure Infectious Disease Diagnostics Product and Solutions
2.19.4 Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Sansure Recent Developments and Future Plans
2.20 Liferiver
2.20.1 Liferiver Details
2.20.2 Liferiver Major Business
2.20.3 Liferiver Infectious Disease Diagnostics Product and Solutions
2.20.4 Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Liferiver Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Infectious Disease Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Disease Diagnostics Players Market Share in 2025
3.2.3 Top 6 Infectious Disease Diagnostics Players Market Share in 2025
3.3 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Disease Diagnostics Market: Region Footprint
3.3.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Disease Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
6.2 North America Infectious Disease Diagnostics Market Size by Application (2021-2032)
6.3 North America Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
9.2 South America Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
9.3 South America Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Infectious Disease Diagnostics Market Drivers
11.2 Infectious Disease Diagnostics Market Restraints
11.3 Infectious Disease Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Disease Diagnostics Industry Chain
12.2 Infectious Disease Diagnostics Upstream Analysis
12.3 Infectious Disease Diagnostics Midstream Analysis
12.4 Infectious Disease Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Disease Diagnostics by Type
1.3.1 Overview: Global Infectious Disease Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2025
1.3.3 Blood Sample
1.3.4 Respiratory Sample
1.3.5 Urine Sample
1.3.6 Other
1.4 Classification of Infectious Disease Diagnostics by Technology
1.4.1 Overview: Global Infectious Disease Diagnostics Market Size by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Technology in 2025
1.4.3 Molecular Diagnostics
1.4.4 Immunodiagnostics
1.4.5 Culture & AST
1.4.6 POCT Rapid Tests
1.4.7 Other
1.5 Classification of Infectious Disease Diagnostics by Test Item
1.5.1 Overview: Global Infectious Disease Diagnostics Market Size by Test Item: 2021 Versus 2025 Versus 2032
1.5.2 Global Infectious Disease Diagnostics Consumption Value Market Share by Test Item in 2025
1.5.3 Respiratory Infections
1.5.4 Hepatitis & Blood-borne
1.5.5 Sexually Transmitted Infections
1.5.6 Gastrointestinal Infections
1.5.7 Other
1.6 Global Infectious Disease Diagnostics Market by Application
1.6.1 Overview: Global Infectious Disease Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Third-party Independent Laboratory
1.6.4 Other
1.7 Global Infectious Disease Diagnostics Market Size & Forecast
1.8 Global Infectious Disease Diagnostics Market Size and Forecast by Region
1.8.1 Global Infectious Disease Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Infectious Disease Diagnostics Market Size by Region, (2021-2032)
1.8.3 North America Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.4 Europe Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.6 South America Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Infectious Disease Diagnostics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Infectious Disease Diagnostics Product and Solutions
2.1.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BD Recent Developments and Future Plans
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business
2.2.3 Danaher Infectious Disease Diagnostics Product and Solutions
2.2.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Danaher Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Infectious Disease Diagnostics Product and Solutions
2.3.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Abbott Recent Developments and Future Plans
2.4 bioM?rieux
2.4.1 bioM?rieux Details
2.4.2 bioM?rieux Major Business
2.4.3 bioM?rieux Infectious Disease Diagnostics Product and Solutions
2.4.4 bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 bioM?rieux Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Infectious Disease Diagnostics Product and Solutions
2.5.4 Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Hologic Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Infectious Disease Diagnostics Product and Solutions
2.6.4 Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Infectious Disease Diagnostics Product and Solutions
2.7.4 Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Roche Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Infectious Disease Diagnostics Product and Solutions
2.8.4 DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 QuidelOrtho
2.9.1 QuidelOrtho Details
2.9.2 QuidelOrtho Major Business
2.9.3 QuidelOrtho Infectious Disease Diagnostics Product and Solutions
2.9.4 QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 QuidelOrtho Recent Developments and Future Plans
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business
2.10.3 Siemens Healthineers Infectious Disease Diagnostics Product and Solutions
2.10.4 Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Siemens Healthineers Recent Developments and Future Plans
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business
2.11.3 Qiagen Infectious Disease Diagnostics Product and Solutions
2.11.4 Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Qiagen Recent Developments and Future Plans
2.12 Bio-Rad
2.12.1 Bio-Rad Details
2.12.2 Bio-Rad Major Business
2.12.3 Bio-Rad Infectious Disease Diagnostics Product and Solutions
2.12.4 Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Bio-Rad Recent Developments and Future Plans
2.13 Wondfo Biotech
2.13.1 Wondfo Biotech Details
2.13.2 Wondfo Biotech Major Business
2.13.3 Wondfo Biotech Infectious Disease Diagnostics Product and Solutions
2.13.4 Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Wondfo Biotech Recent Developments and Future Plans
2.14 Autobio
2.14.1 Autobio Details
2.14.2 Autobio Major Business
2.14.3 Autobio Infectious Disease Diagnostics Product and Solutions
2.14.4 Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Autobio Recent Developments and Future Plans
2.15 Daan Gene
2.15.1 Daan Gene Details
2.15.2 Daan Gene Major Business
2.15.3 Daan Gene Infectious Disease Diagnostics Product and Solutions
2.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Daan Gene Recent Developments and Future Plans
2.16 Innovita
2.16.1 Innovita Details
2.16.2 Innovita Major Business
2.16.3 Innovita Infectious Disease Diagnostics Product and Solutions
2.16.4 Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Innovita Recent Developments and Future Plans
2.17 Hybribio
2.17.1 Hybribio Details
2.17.2 Hybribio Major Business
2.17.3 Hybribio Infectious Disease Diagnostics Product and Solutions
2.17.4 Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Hybribio Recent Developments and Future Plans
2.18 BioPerfectus
2.18.1 BioPerfectus Details
2.18.2 BioPerfectus Major Business
2.18.3 BioPerfectus Infectious Disease Diagnostics Product and Solutions
2.18.4 BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 BioPerfectus Recent Developments and Future Plans
2.19 Sansure
2.19.1 Sansure Details
2.19.2 Sansure Major Business
2.19.3 Sansure Infectious Disease Diagnostics Product and Solutions
2.19.4 Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Sansure Recent Developments and Future Plans
2.20 Liferiver
2.20.1 Liferiver Details
2.20.2 Liferiver Major Business
2.20.3 Liferiver Infectious Disease Diagnostics Product and Solutions
2.20.4 Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Liferiver Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Disease Diagnostics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Infectious Disease Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Disease Diagnostics Players Market Share in 2025
3.2.3 Top 6 Infectious Disease Diagnostics Players Market Share in 2025
3.3 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Disease Diagnostics Market: Region Footprint
3.3.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Disease Diagnostics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Infectious Disease Diagnostics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2026)
5.2 Global Infectious Disease Diagnostics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
6.2 North America Infectious Disease Diagnostics Market Size by Application (2021-2032)
6.3 North America Infectious Disease Diagnostics Market Size by Country
6.3.1 North America Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
6.3.2 United States Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
6.3.3 Canada Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
6.3.4 Mexico Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
7.2 Europe Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
7.3 Europe Infectious Disease Diagnostics Market Size by Country
7.3.1 Europe Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
7.3.2 Germany Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.3 France Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.5 Russia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
7.3.6 Italy Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2021-2032)
8.3.2 China Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.3 Japan Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.4 South Korea Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.5 India Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
8.3.7 Australia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
9.2 South America Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
9.3 South America Infectious Disease Diagnostics Market Size by Country
9.3.1 South America Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
9.3.2 Brazil Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
9.3.3 Argentina Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2021-2032)
10.3.2 Turkey Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
10.3.4 UAE Infectious Disease Diagnostics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Infectious Disease Diagnostics Market Drivers
11.2 Infectious Disease Diagnostics Market Restraints
11.3 Infectious Disease Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Disease Diagnostics Industry Chain
12.2 Infectious Disease Diagnostics Upstream Analysis
12.3 Infectious Disease Diagnostics Midstream Analysis
12.4 Infectious Disease Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infectious Disease Diagnostics Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Infectious Disease Diagnostics Consumption Value by Test Item, (USD Million), 2021 & 2025 & 2032
Table 4. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Infectious Disease Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. BD Company Information, Head Office, and Major Competitors
Table 8. BD Major Business
Table 9. BD Infectious Disease Diagnostics Product and Solutions
Table 10. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. BD Recent Developments and Future Plans
Table 12. Danaher Company Information, Head Office, and Major Competitors
Table 13. Danaher Major Business
Table 14. Danaher Infectious Disease Diagnostics Product and Solutions
Table 15. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Danaher Recent Developments and Future Plans
Table 17. Abbott Company Information, Head Office, and Major Competitors
Table 18. Abbott Major Business
Table 19. Abbott Infectious Disease Diagnostics Product and Solutions
Table 20. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. bioM?rieux Company Information, Head Office, and Major Competitors
Table 22. bioM?rieux Major Business
Table 23. bioM?rieux Infectious Disease Diagnostics Product and Solutions
Table 24. bioM?rieux Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. bioM?rieux Recent Developments and Future Plans
Table 26. Hologic Company Information, Head Office, and Major Competitors
Table 27. Hologic Major Business
Table 28. Hologic Infectious Disease Diagnostics Product and Solutions
Table 29. Hologic Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Hologic Recent Developments and Future Plans
Table 31. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 32. Thermo Fisher Scientific Major Business
Table 33. Thermo Fisher Scientific Infectious Disease Diagnostics Product and Solutions
Table 34. Thermo Fisher Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Thermo Fisher Scientific Recent Developments and Future Plans
Table 36. Roche Company Information, Head Office, and Major Competitors
Table 37. Roche Major Business
Table 38. Roche Infectious Disease Diagnostics Product and Solutions
Table 39. Roche Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Roche Recent Developments and Future Plans
Table 41. DiaSorin Company Information, Head Office, and Major Competitors
Table 42. DiaSorin Major Business
Table 43. DiaSorin Infectious Disease Diagnostics Product and Solutions
Table 44. DiaSorin Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. DiaSorin Recent Developments and Future Plans
Table 46. QuidelOrtho Company Information, Head Office, and Major Competitors
Table 47. QuidelOrtho Major Business
Table 48. QuidelOrtho Infectious Disease Diagnostics Product and Solutions
Table 49. QuidelOrtho Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. QuidelOrtho Recent Developments and Future Plans
Table 51. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 52. Siemens Healthineers Major Business
Table 53. Siemens Healthineers Infectious Disease Diagnostics Product and Solutions
Table 54. Siemens Healthineers Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Siemens Healthineers Recent Developments and Future Plans
Table 56. Qiagen Company Information, Head Office, and Major Competitors
Table 57. Qiagen Major Business
Table 58. Qiagen Infectious Disease Diagnostics Product and Solutions
Table 59. Qiagen Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Qiagen Recent Developments and Future Plans
Table 61. Bio-Rad Company Information, Head Office, and Major Competitors
Table 62. Bio-Rad Major Business
Table 63. Bio-Rad Infectious Disease Diagnostics Product and Solutions
Table 64. Bio-Rad Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Bio-Rad Recent Developments and Future Plans
Table 66. Wondfo Biotech Company Information, Head Office, and Major Competitors
Table 67. Wondfo Biotech Major Business
Table 68. Wondfo Biotech Infectious Disease Diagnostics Product and Solutions
Table 69. Wondfo Biotech Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Wondfo Biotech Recent Developments and Future Plans
Table 71. Autobio Company Information, Head Office, and Major Competitors
Table 72. Autobio Major Business
Table 73. Autobio Infectious Disease Diagnostics Product and Solutions
Table 74. Autobio Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Autobio Recent Developments and Future Plans
Table 76. Daan Gene Company Information, Head Office, and Major Competitors
Table 77. Daan Gene Major Business
Table 78. Daan Gene Infectious Disease Diagnostics Product and Solutions
Table 79. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Daan Gene Recent Developments and Future Plans
Table 81. Innovita Company Information, Head Office, and Major Competitors
Table 82. Innovita Major Business
Table 83. Innovita Infectious Disease Diagnostics Product and Solutions
Table 84. Innovita Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Innovita Recent Developments and Future Plans
Table 86. Hybribio Company Information, Head Office, and Major Competitors
Table 87. Hybribio Major Business
Table 88. Hybribio Infectious Disease Diagnostics Product and Solutions
Table 89. Hybribio Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Hybribio Recent Developments and Future Plans
Table 91. BioPerfectus Company Information, Head Office, and Major Competitors
Table 92. BioPerfectus Major Business
Table 93. BioPerfectus Infectious Disease Diagnostics Product and Solutions
Table 94. BioPerfectus Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. BioPerfectus Recent Developments and Future Plans
Table 96. Sansure Company Information, Head Office, and Major Competitors
Table 97. Sansure Major Business
Table 98. Sansure Infectious Disease Diagnostics Product and Solutions
Table 99. Sansure Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Sansure Recent Developments and Future Plans
Table 101. Liferiver Company Information, Head Office, and Major Competitors
Table 102. Liferiver Major Business
Table 103. Liferiver Infectious Disease Diagnostics Product and Solutions
Table 104. Liferiver Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Liferiver Recent Developments and Future Plans
Table 106. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 107. Global Infectious Disease Diagnostics Revenue Share by Players (2021-2026)
Table 108. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 109. Market Position of Players in Infectious Disease Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 110. Head Office of Key Infectious Disease Diagnostics Players
Table 111. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 112. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 113. Infectious Disease Diagnostics New Market Entrants and Barriers to Market Entry
Table 114. Infectious Disease Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 115. Global Infectious Disease Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 116. Global Infectious Disease Diagnostics Consumption Value Share by Type (2021-2026)
Table 117. Global Infectious Disease Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 118. Global Infectious Disease Diagnostics Consumption Value by Application (2021-2026)
Table 119. Global Infectious Disease Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 120. North America Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 121. North America Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 122. North America Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 123. North America Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 124. North America Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 125. North America Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Europe Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Europe Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Europe Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 129. Europe Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 130. Europe Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 137. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 138. South America Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 139. South America Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 140. South America Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 141. South America Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 142. South America Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 143. South America Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 147. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 148. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 149. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 150. Global Key Players of Infectious Disease Diagnostics Upstream (Raw Materials)
Table 151. Global Infectious Disease Diagnostics Typical Customers
Table 1. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infectious Disease Diagnostics Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Infectious Disease Diagnostics Consumption Value by Test Item, (USD Million), 2021 & 2025 & 2032
Table 4. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Infectious Disease Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 7. BD Company Information, Head Office, and Major Competitors
Table 8. BD Major Business
Table 9. BD Infectious Disease Diagnostics Product and Solutions
Table 10. BD Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. BD Recent Developments and Future Plans
Table 12. Danaher Company Information, Head Office, and Major Competitors
Table 13. Danaher Major Business
Table 14. Danaher Infectious Disease Diagnostics Product and Solutions
Table 15. Danaher Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Danaher Recent Developments and Future Plans
Table 17. Abbott Company Information, Head Office, and Major Competitors
Table 18. Abbott Major Business
Table 19. Abbott Infectious Disease Diagnostics Product and Solutions
Table 20. Abbott Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. bioM?rieux Company Information, Head Office, and Major Competitors
Table 22. bioM?rieux Major Business
Table 23. bioM?rieux Infectious Disease Diagnostics Product and Solutions
Table 24. bioM?rieux Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. bioM?rieux Recent Developments and Future Plans
Table 26. Hologic Company Information, Head Office, and Major Competitors
Table 27. Hologic Major Business
Table 28. Hologic Infectious Disease Diagnostics Product and Solutions
Table 29. Hologic Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Hologic Recent Developments and Future Plans
Table 31. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 32. Thermo Fisher Scientific Major Business
Table 33. Thermo Fisher Scientific Infectious Disease Diagnostics Product and Solutions
Table 34. Thermo Fisher Scientific Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Thermo Fisher Scientific Recent Developments and Future Plans
Table 36. Roche Company Information, Head Office, and Major Competitors
Table 37. Roche Major Business
Table 38. Roche Infectious Disease Diagnostics Product and Solutions
Table 39. Roche Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Roche Recent Developments and Future Plans
Table 41. DiaSorin Company Information, Head Office, and Major Competitors
Table 42. DiaSorin Major Business
Table 43. DiaSorin Infectious Disease Diagnostics Product and Solutions
Table 44. DiaSorin Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. DiaSorin Recent Developments and Future Plans
Table 46. QuidelOrtho Company Information, Head Office, and Major Competitors
Table 47. QuidelOrtho Major Business
Table 48. QuidelOrtho Infectious Disease Diagnostics Product and Solutions
Table 49. QuidelOrtho Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. QuidelOrtho Recent Developments and Future Plans
Table 51. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 52. Siemens Healthineers Major Business
Table 53. Siemens Healthineers Infectious Disease Diagnostics Product and Solutions
Table 54. Siemens Healthineers Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Siemens Healthineers Recent Developments and Future Plans
Table 56. Qiagen Company Information, Head Office, and Major Competitors
Table 57. Qiagen Major Business
Table 58. Qiagen Infectious Disease Diagnostics Product and Solutions
Table 59. Qiagen Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Qiagen Recent Developments and Future Plans
Table 61. Bio-Rad Company Information, Head Office, and Major Competitors
Table 62. Bio-Rad Major Business
Table 63. Bio-Rad Infectious Disease Diagnostics Product and Solutions
Table 64. Bio-Rad Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Bio-Rad Recent Developments and Future Plans
Table 66. Wondfo Biotech Company Information, Head Office, and Major Competitors
Table 67. Wondfo Biotech Major Business
Table 68. Wondfo Biotech Infectious Disease Diagnostics Product and Solutions
Table 69. Wondfo Biotech Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Wondfo Biotech Recent Developments and Future Plans
Table 71. Autobio Company Information, Head Office, and Major Competitors
Table 72. Autobio Major Business
Table 73. Autobio Infectious Disease Diagnostics Product and Solutions
Table 74. Autobio Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Autobio Recent Developments and Future Plans
Table 76. Daan Gene Company Information, Head Office, and Major Competitors
Table 77. Daan Gene Major Business
Table 78. Daan Gene Infectious Disease Diagnostics Product and Solutions
Table 79. Daan Gene Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Daan Gene Recent Developments and Future Plans
Table 81. Innovita Company Information, Head Office, and Major Competitors
Table 82. Innovita Major Business
Table 83. Innovita Infectious Disease Diagnostics Product and Solutions
Table 84. Innovita Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Innovita Recent Developments and Future Plans
Table 86. Hybribio Company Information, Head Office, and Major Competitors
Table 87. Hybribio Major Business
Table 88. Hybribio Infectious Disease Diagnostics Product and Solutions
Table 89. Hybribio Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Hybribio Recent Developments and Future Plans
Table 91. BioPerfectus Company Information, Head Office, and Major Competitors
Table 92. BioPerfectus Major Business
Table 93. BioPerfectus Infectious Disease Diagnostics Product and Solutions
Table 94. BioPerfectus Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. BioPerfectus Recent Developments and Future Plans
Table 96. Sansure Company Information, Head Office, and Major Competitors
Table 97. Sansure Major Business
Table 98. Sansure Infectious Disease Diagnostics Product and Solutions
Table 99. Sansure Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Sansure Recent Developments and Future Plans
Table 101. Liferiver Company Information, Head Office, and Major Competitors
Table 102. Liferiver Major Business
Table 103. Liferiver Infectious Disease Diagnostics Product and Solutions
Table 104. Liferiver Infectious Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Liferiver Recent Developments and Future Plans
Table 106. Global Infectious Disease Diagnostics Revenue (USD Million) by Players (2021-2026)
Table 107. Global Infectious Disease Diagnostics Revenue Share by Players (2021-2026)
Table 108. Breakdown of Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 109. Market Position of Players in Infectious Disease Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 110. Head Office of Key Infectious Disease Diagnostics Players
Table 111. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 112. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 113. Infectious Disease Diagnostics New Market Entrants and Barriers to Market Entry
Table 114. Infectious Disease Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 115. Global Infectious Disease Diagnostics Consumption Value (USD Million) by Type (2021-2026)
Table 116. Global Infectious Disease Diagnostics Consumption Value Share by Type (2021-2026)
Table 117. Global Infectious Disease Diagnostics Consumption Value Forecast by Type (2027-2032)
Table 118. Global Infectious Disease Diagnostics Consumption Value by Application (2021-2026)
Table 119. Global Infectious Disease Diagnostics Consumption Value Forecast by Application (2027-2032)
Table 120. North America Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 121. North America Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 122. North America Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 123. North America Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 124. North America Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 125. North America Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Europe Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Europe Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Europe Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 129. Europe Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 130. Europe Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 137. Asia-Pacific Infectious Disease Diagnostics Consumption Value by Region (2027-2032) & (USD Million)
Table 138. South America Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 139. South America Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 140. South America Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 141. South America Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 142. South America Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 143. South America Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2021-2026) & (USD Million)
Table 147. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Application (2027-2032) & (USD Million)
Table 148. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2021-2026) & (USD Million)
Table 149. Middle East & Africa Infectious Disease Diagnostics Consumption Value by Country (2027-2032) & (USD Million)
Table 150. Global Key Players of Infectious Disease Diagnostics Upstream (Raw Materials)
Table 151. Global Infectious Disease Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. Blood Sample
Figure 5. Respiratory Sample
Figure 6. Urine Sample
Figure 7. Other
Figure 8. Global Infectious Disease Diagnostics Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Infectious Disease Diagnostics Consumption Value Market Share by Technology in 2025
Figure 10. Molecular Diagnostics
Figure 11. Immunodiagnostics
Figure 12. Culture & AST
Figure 13. POCT Rapid Tests
Figure 14. Other
Figure 15. Global Infectious Disease Diagnostics Consumption Value by Test Item, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Infectious Disease Diagnostics Consumption Value Market Share by Test Item in 2025
Figure 17. Respiratory Infections
Figure 18. Hepatitis & Blood-borne
Figure 19. Sexually Transmitted Infections
Figure 20. Gastrointestinal Infections
Figure 21. Other
Figure 22. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. Infectious Disease Diagnostics Consumption Value Market Share by Application in 2025
Figure 24. Public Hospitals Picture
Figure 25. Third-party Independent Laboratory Picture
Figure 26. Other Picture
Figure 27. Global Infectious Disease Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 28. Global Infectious Disease Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 29. Global Market Infectious Disease Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 30. Global Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 31. Global Infectious Disease Diagnostics Consumption Value Market Share by Region in 2025
Figure 32. North America Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 37. Company Three Recent Developments and Future Plans
Figure 38. Global Infectious Disease Diagnostics Revenue Share by Players in 2025
Figure 39. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 40. Market Share of Infectious Disease Diagnostics by Player Revenue in 2025
Figure 41. Top 3 Infectious Disease Diagnostics Players Market Share in 2025
Figure 42. Top 6 Infectious Disease Diagnostics Players Market Share in 2025
Figure 43. Global Infectious Disease Diagnostics Consumption Value Share by Type (2021-2026)
Figure 44. Global Infectious Disease Diagnostics Market Share Forecast by Type (2027-2032)
Figure 45. Global Infectious Disease Diagnostics Consumption Value Share by Application (2021-2026)
Figure 46. Global Infectious Disease Diagnostics Market Share Forecast by Application (2027-2032)
Figure 47. North America Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 48. North America Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 49. North America Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 54. Europe Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 55. Europe Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 56. Germany Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. France Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. United Kingdom Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 59. Russia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 60. Italy Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 61. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 62. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 63. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 64. China Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 67. India Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 71. South America Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 72. South America Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 80. UAE Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 81. Infectious Disease Diagnostics Market Drivers
Figure 82. Infectious Disease Diagnostics Market Restraints
Figure 83. Infectious Disease Diagnostics Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Infectious Disease Diagnostics Industrial Chain
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. Global Infectious Disease Diagnostics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infectious Disease Diagnostics Consumption Value Market Share by Type in 2025
Figure 4. Blood Sample
Figure 5. Respiratory Sample
Figure 6. Urine Sample
Figure 7. Other
Figure 8. Global Infectious Disease Diagnostics Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Infectious Disease Diagnostics Consumption Value Market Share by Technology in 2025
Figure 10. Molecular Diagnostics
Figure 11. Immunodiagnostics
Figure 12. Culture & AST
Figure 13. POCT Rapid Tests
Figure 14. Other
Figure 15. Global Infectious Disease Diagnostics Consumption Value by Test Item, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Infectious Disease Diagnostics Consumption Value Market Share by Test Item in 2025
Figure 17. Respiratory Infections
Figure 18. Hepatitis & Blood-borne
Figure 19. Sexually Transmitted Infections
Figure 20. Gastrointestinal Infections
Figure 21. Other
Figure 22. Global Infectious Disease Diagnostics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. Infectious Disease Diagnostics Consumption Value Market Share by Application in 2025
Figure 24. Public Hospitals Picture
Figure 25. Third-party Independent Laboratory Picture
Figure 26. Other Picture
Figure 27. Global Infectious Disease Diagnostics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 28. Global Infectious Disease Diagnostics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 29. Global Market Infectious Disease Diagnostics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 30. Global Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 31. Global Infectious Disease Diagnostics Consumption Value Market Share by Region in 2025
Figure 32. North America Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 37. Company Three Recent Developments and Future Plans
Figure 38. Global Infectious Disease Diagnostics Revenue Share by Players in 2025
Figure 39. Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 40. Market Share of Infectious Disease Diagnostics by Player Revenue in 2025
Figure 41. Top 3 Infectious Disease Diagnostics Players Market Share in 2025
Figure 42. Top 6 Infectious Disease Diagnostics Players Market Share in 2025
Figure 43. Global Infectious Disease Diagnostics Consumption Value Share by Type (2021-2026)
Figure 44. Global Infectious Disease Diagnostics Market Share Forecast by Type (2027-2032)
Figure 45. Global Infectious Disease Diagnostics Consumption Value Share by Application (2021-2026)
Figure 46. Global Infectious Disease Diagnostics Market Share Forecast by Application (2027-2032)
Figure 47. North America Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 48. North America Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 49. North America Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 54. Europe Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 55. Europe Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 56. Germany Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 57. France Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 58. United Kingdom Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 59. Russia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 60. Italy Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 61. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 62. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 63. Asia-Pacific Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 64. China Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 67. India Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 71. South America Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 72. South America Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Infectious Disease Diagnostics Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 80. UAE Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 81. Infectious Disease Diagnostics Market Drivers
Figure 82. Infectious Disease Diagnostics Market Restraints
Figure 83. Infectious Disease Diagnostics Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Infectious Disease Diagnostics Industrial Chain
Figure 86. Methodology
Figure 87. Research Process and Data Source
